| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Watch List Logout |
| Recent advancements in product development are highlighted by the positive outcomes from the phase 3 clinical trial of ruxolitinib cream, showcasing a strong potential for market success. Additionally, the introduction of new leadership suggests a commitment to enhancing strategic development efforts. These factors position the company favorably in a competitive pharmaceutical landscape. However, the reliance on clinical trial outcomes can introduce uncertainty, as future trials may not yield similar success. |
| The price action of Incyte Corp (INCY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.4 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for INCY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.6, and the negative at -0.2 on 2025-09-28. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| INCY | |||||||||||||
| Date | Attention | Price | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-28 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2025-09-27 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-09-26 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-09-25 | 0%(0%) | 0 | 0% | 0.5 | 3.8 | -1 | |||||||
| 2025-09-24 | 0%(0%) | 0 | 0% | 0.5 | 4 | -1 | |||||||
| 2025-09-23 | 0%(0%) | 0 | 0% | 0.6 | 4.3 | -1 | |||||||
| 2025-09-22 | 0%(0%) | 0 | 0% | 0.6 | 4.3 | -1 | |||||||
| 2025-09-21 | 0%(0%) | 0 | 0% | 0.6 | 4.6 | -1 | |||||||
| 2025-09-20 | 0%(0%) | 0 | 0% | 0.6 | 4.6 | -1 | |||||||
| 2025-09-18 | 0%(0%) | 0 | 0% | 0.6 | 4.6 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2026-01-11 12:27:43 Collaborations among companies, such as between CMS and Dermavon, signify strategic partnerships aimed at advancing health innovations and therapies. |
| 2026-01-11 12:27:43 The need for regulatory approvals for new treatments like ruxolitinib cream is highlighted, indicating the essential compliance processes in pharmaceutical developments. |
| 2026-01-11 12:27:43 The success of innovative products opens up new market opportunities for pharmaceutical companies, encouraging further investments and partnerships. |
| 2026-01-11 12:27:43 The development of new treatments like ruxolitinib cream reflects ongoing innovation in dermatology, contributing to improved patient care and health outcomes. |
| 2026-01-11 12:27:43 The positive results from the phase 3 clinical trial of ruxolitinib cream indicate significant advancements in product development within the pharmaceutical industry. |